Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

Pregnant women with a common form of fatty liver disease are more likely to deliver their babies early, according to a new ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Biomedical research in liver diseases has traditionally depended on animal models, but ethical concerns and the quest for ...

Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...